
Overview
The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal.
Dr. Wilcox is highly rated in 24 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.
Dr. Wilcox is board certified in Hematology, Internal Medicine, and Medical Oncology. He is actively involved in clinical research, co-authoring 106 peer reviewed articles and participating in 5 clinical trials. Dr. Wilcox is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
1500 E Medical Center Dr, Floor B1 Reception A, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
University Of Michigan Medical Center
Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.
Frequently Asked Questions about Dr. Ryan A. Wilcox
How do I make an appointment with Dr. Ryan A. Wilcox?
You can book an appointment with Dr. Ryan A. Wilcox by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ryan A. Wilcox a top-rated expert for T-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ryan A. Wilcox is classified as an Elite expert for T-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ryan A. Wilcox specialize in?
While Dr. Ryan A. Wilcox is a Oncology, they have specific expertise in T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Peripheral T-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Ryan A. Wilcox participate in research or clinical trials?
Yes. Dr. Ryan A. Wilcox has published 106 articles and abstracts on conditions like T-Cell Lymphoma. You can view a list of Dr. Ryan A. Wilcox's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ryan A. Wilcox accept my insurance?
Dr. Ryan A. Wilcox accepts most major insurance plans, including Blue Cross Blue Shield and EMI Health. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cutaneous T-Cell Lymphoma (CTCL)
- Non-Hodgkin LymphomaDr. Wilcox isElite. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaDr. Wilcox isElite. Learn about Peripheral T-Cell Lymphoma.
- Sezary SyndromeDr. Wilcox isElite. Learn about Sezary Syndrome.
- T-Cell LymphomaDr. Wilcox isElite. Learn about T-Cell Lymphoma.
- Distinguished
- Anaplastic Large Cell LymphomaDr. Wilcox isDistinguished. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Wilcox isDistinguished. Learn about Angioimmunoblastic T-cell Lymphoma.
- Follicular LymphomaDr. Wilcox isDistinguished. Learn about Follicular Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Wilcox isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Advanced
- Adult T-Cell LeukemiaDr. Wilcox isAdvanced. Learn about Adult T-Cell Leukemia.
- B-Cell LymphomaDr. Wilcox isAdvanced. Learn about B-Cell Lymphoma.
- Chronic T-Cell Leukemia (CTCL)Dr. Wilcox isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Classical Hodgkin LymphomaDr. Wilcox isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Familial Wilms Tumor 2Dr. Wilcox isAdvanced. Learn about Familial Wilms Tumor 2.
- Gastric LymphomaDr. Wilcox isAdvanced. Learn about Gastric Lymphoma.
- HistiocytosisDr. Wilcox isAdvanced. Learn about Histiocytosis.
- Hodgkin LymphomaDr. Wilcox isAdvanced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Wilcox isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Marginal Zone Lymphoma (MZL)Dr. Wilcox isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Midline Lethal GranulomaDr. Wilcox isAdvanced. Learn about Midline Lethal Granuloma.
- ReticulohistiocytomaDr. Wilcox isAdvanced. Learn about Reticulohistiocytoma.
- Small Lymphocytic Lymphoma (SLL)Dr. Wilcox isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- Bone Marrow AspirationDr. Wilcox isExperienced. Learn about Bone Marrow Aspiration.
- Burkitt LymphomaDr. Wilcox isExperienced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Wilcox isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Wilcox isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- DRESS SyndromeDr. Wilcox isExperienced. Learn about DRESS Syndrome.
- Felty SyndromeDr. Wilcox isExperienced. Learn about Felty Syndrome.
- Hemophagocytic LymphohistiocytosisDr. Wilcox isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- LeukemiaDr. Wilcox isExperienced. Learn about Leukemia.
- Lymphofollicular HyperplasiaDr. Wilcox isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lymphoid HyperplasiaDr. Wilcox isExperienced. Learn about Lymphoid Hyperplasia.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Non-Langerhans-Cell HistiocytosisDr. Wilcox isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- Primary Lymphoma of the BrainDr. Wilcox isExperienced. Learn about Primary Lymphoma of the Brain.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- Prolymphocytic LeukemiaDr. Wilcox isExperienced. Learn about Prolymphocytic Leukemia.
- Richter SyndromeDr. Wilcox isExperienced. Learn about Richter Syndrome.
- Schnitzler SyndromeDr. Wilcox isExperienced. Learn about Schnitzler Syndrome.
- SplenomegalyDr. Wilcox isExperienced. Learn about Splenomegaly.
- Virus Associated Hemophagocytic Syndrome
- Waldenstrom MacroglobulinemiaDr. Wilcox isExperienced. Learn about Waldenstrom Macroglobulinemia.

